Publikace
- Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed2017 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab2017 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics2016 | Lékařská fakulta v Plzni
- High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib2015 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Přírodovědecká fakulta
- The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study2015 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib2014 | Lékařská fakulta v Plzni
- Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?2024 | Lékařská fakulta v Plzni
- Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate2024 | Lékařská fakulta v Plzni
- Pembrolizumab plus enfortumab vedotin in urothelial cancer2024 | Lékařská fakulta v Plzni
Loading network view...